Antimicrobials and Resistance Flashcards
Inhibition of cell wall synthesis
B lactam antimicrobials
Polypeptide antimicrobials
Glycopeptide antimicrobials
B lactam antimicrobials
contain B lactam ring
differentiated by the chemical side chains attached to the ring
prevent cross linking of peptidoglycan
B lactam antimicrobials mode of action
ability to inhibit PBPs that are essential for peptidoglycan synthesis
PBPs
transpeptidases that cross link peptidoglycan
located on the external side of the bacterial plasma membrane
Penicillins
Penicillin
Ampicillin
Oxacillin
Carbapenems
Meropenem
Monobactem
Aztreonem
Cephalosporins
1-5th gen
Polypeptide antimicrobials
Bacitracin
Bacitracin
inhibits synthesis of cell wall at an earlier stage than B lactam antimicrobials
interferes with synthesis of the linear carbohydrate strands for peptidoglycan
Glycopeptide antimicrobials
Vancomycin
Vancomycin
inhibition of cell wall synthesis by complexing with the D-alanyl-D-alanine portion of the peptide cross links
B lactam antimicrobials
penicillins
carbapenems
monobactem
cephalosporins
Inhibition of protein synthesis
chloramphenicol aminoglycosides tetracyclines macrolides lincosamides
Chloramphenicol
binds to 50S portion and inhibits formation of peptide bond
Aminoglycosides
changes shape of 30S portion, preventing 50S ribosome from forming 70S complex causing code on mRNA to be read incorrectly
Tetracyclines
interfere with attachment to tRNA to mRNA - 30S ribosome complex
Macrolides
bind to 50S subunit blocking the translocation reaction of polypeptide chain elongation
Lincosamides
bind to 50S subunit blocking the translocation reaction of polypeptide chain elongation
Inhibition of nucleic acid replication and transcription
Rifamycin
Fluoroquinolones
Rifamycin
forms a complex with bacterial RNA polymerase preventing the initiation process of DNA transcription
Fluoroquinolones
block bacterial DNA synthesis by inhibiting bacterial topoisomerase II (DNA gyrase) and topoisomerase IV (ciprofloxacin, levofloxacin)
Injury to plasma membrane
lipopeptides
Lipopeptides
daptomycin
polymyxin B
Daptomycin
binds to cell membrane and alters structure making it more permeable which leads to cell death
Polymyxin B
interacts with phospholipids of bacterial cell membranes increasing cell permeability and causing cell lysis
Inhibition of essential metabolite synthesis
sulfonamides
trimethoprim
Sulfonamides
structurally similar to folic acid precursor (PABA), allowing them to competitively bind with the enzyme meant for PABA and thereby block folic acid production
Folic acid
important coenzyme in bacteria needed for synthesis of proteins
Trimethoprim
structurally similar to dihydrofolic acid allowing for competitive inhibition of enzyme meant for dihydrofolic acid thereby blocking folic acid production
Bacterial enzymatic destruction of antimicrobial agent
B lactamase mediated resistance
B lactamase mediated resistance
able to break down some penicillins, cephalosporins, and carbapenems
Bacterial enzymatic alteration of antimicrobial agent
aminoglycoside resistance
Aminoglycoside resistance
bacterial enzymes modify aminoglycosides resulting in decreased binding to 30S ribosome therefore making the antimicrobial inactive
Efflux (ejection) of antimicrobial agent from bacteria
Tetracycline resistance
Tetracycline resistance
efflux pump removes antimicrobial from cytoplasm so that it can’t interfere with tRNA attachment so proteins synthesis can continue
Alteration of the antimicrobial agents target site
Oxacillin (methicillin) resistance
Vancomycin resistance
Oxacillin (methicillin) resistance
penicillin binding protein mediated resistance
MRSA has PBP2a coded by mecA gene
Vancomycin resistance
altered peptidoglycan cross link target so vancomycin can’t bind and prevent the transpeptidase cross linking of peptidoglycan
vanA and vanB most common genes coding for resistance
Blocking entry to antimicrobial agents target site in bacteria
B lactam, Tetracycline, and Fluoroquinolone resistance
B lactam, Tetracycline, and Fluoroquinolone resistance
porin channel mediated blocked entry prevents antimicrobial from reaching target site
Target bypass
Trimethoprim/Sulfamethoxazole resistance
Trimethoprim/Sulfamethoxazole resistance
Bacteria increases the production of the antimicrobial target with the objective of overwhelming the antibiotic by increasing the amount of targets available
2 enzymes DHFR or DHPS are overproduced through mutations in the DNA encoding these enzymes so folate production can continue